The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers

Endocrinology (United States)

Volumn 155, Issue 9, 2014, Pages 3227-3237

  Girgis, Christian M ^a,b   Mokbel, Nancy ^a   Cha, Kuan Minn ^a   Houweling, Peter J ^c,d   Abboud, Myriam ^b,c   Fraser, David R ^b   Mason, Rebecca S ^b,c   Clifton Bligh, Roderick J ^b,e,f   Gunton, Jenny E ^a,g,h  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Facultie of Medicine   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ROYAL NORTH SHORE HOSPITAL   (Australia)

^g WESTMEAD HOSPITAL   (Australia)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; CALCITRIOL RECEPTOR; DRUG DERIVATIVE; VITAMIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYP27B1 GENE; DRUG UPTAKE; GENE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOLECULAR CLONING; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MYOTUBE; NONHUMAN; QUADRICEPS FEMORIS MUSCLE; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SKELETAL MUSCLE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; GENETICS; KNOCKOUT MOUSE; METABOLISM; MUSCLE FIBRIL; TRANSPORT AT THE CELLULAR LEVEL; VITAMIN D DEFICIENCY;

ANIMALS; BIOLOGICAL TRANSPORT; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MYOFIBRILS; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84907048416     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1016     Document Type: Article

References (67)

1. Glisson F. A Treatise of the Rickets: Being a Disease Common to Children. Culpeper N, ed. London, UK: P. Cole; 1651.
2. Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013;34:33-83.
3. Murad MH, Elamin KB, Abu Elnour NO, et al. The effectofvitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:1911-1930.
4. Ward KA, Das G, Roberts SA, et al. A randomized, controlled trial of vitamin D supplementation upon musculoskeletal health in post-menarchal females. J Clin Endocrinol Metab. 2010;95:4643-4651.
5. Sohl E, van Schoor NM, de Jongh RT, Visser M, Deeg DJ, Lips P. Vitamin d status is associated with functional limitations and functional decline in older individuals. J Clin Endocrinol Metab. 2013; 98:E1483-E1490.
6. Boland RL. VDR activation of intracellular signaling pathways in skeletal muscle. Mol Cell Endocrinol. 2011;347:11-16.
7. Abboud M, Puglisi DA, Davies BN, et al. Evidence for a specific uptake and retention mechanism for 25-hydroxyvitamin D (25OHD) in skeletal muscle cells. Endocrinology. 2013;154:3022-3030.
8. Garcia LA, Ferrini MG, Norris KC, Artaza JN. 1, 25(OH)(2)vitamin D(3) enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C(2)C(12) skeletal muscle cells. J Steroid Biochem Mol Biol. 2013; 133:1-11.
9. Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN. 1, 25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of pro-myogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology. 2011;152:2976-2986.
10. Girgis CM, Clifton-Bligh RJ, Mokbel N, Cheng K, Gunton JE. Vitamin D signaling regulates proliferation, differentiation, and myo-tube size in C2C12 skeletal muscle cells. Endocrinology. 2014;155: 347-357.
11. Simpson RU, Thomas GA, Arnold AJ. Identification of 1, 25-dihy-droxyvitamin D3 receptors and activities in muscle. J Biol Chem. 1985;260:8882-8891.
12. Wang Y, DeLuca HF. Is the vitamin d receptor found in muscle? Endocrinology. 2011;152:354-363.
13. Bischoff HA, Borchers M, Gudat F, et al. In situ detection of 1, 25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. His-tochem J. 2001;33:19-24.
14. Srikuea R, Zhang X, Park-Sarge OK, Esser KA. VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol. 2012;303:C396-C405.
15. Ceglia L, da Silva Morais M, Park LK, et al. Multi-step immuno-fluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. J Mol Histol. 2010;41: 137-142.
16. Ceglia L, Niramitmahapanya S, da Silva Morais M, et al. A randomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab. 2013;98:E1927-E1935.
17. Decary S, Mouly V, Hamida CB, Sautet A, Barbet JP, Butler-Browne GS. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum Gene Ther. 1997;8:1429-1438.
18. Mokbel N, Hoffman NJ, Girgis CM, et al. Grb10 deletion enhances muscle cell proliferation, differentiation and GLUT4 plasma membrane translocation [published online March 24, 2014]. J Cell Physiol. doi:10.1002/jcp.24628.
19. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 1977;270: 725-727.
20. Andres V, Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol. 1996;132:657-666.
21. Fujita H, Endo A, Shimizu K, Nagamori E. Evaluation of serum-free differentiation conditions for C2C12 myoblast cells assessed as to active tension generation capability. Biotechnol Bioeng. 2010;107: 894-901.
22. Amling M, Priemel M, Holzmann T, et al. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and bio-mechanical analyses. Endocrinology. 1999;140:4982-4987.
23. Cheng K, Ho K, Stokes R, et al. Hypoxia-inducible factor-1a regulates β cell function in mouse and human islets. J Clin Invest. 2010; 120:2171-2183.
24. Lau SM, Cha KM, Karunatillake A, et al. β-Cell ARNT is required for normal glucose tolerance in murine pregnancy. PLoS One. 2013; 8:e77419.
25. Gunton JE, Delhanty PJ, Takahashi S, Baxter RC. Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2. J Clin Endocrinol Metab. 2003;88:1323-1332.
26. Wang Y, Becklund BR, DeLuca HF. Identification of a highly specific and versatile vitamin D receptor antibody. Arch Biochem Bio-phys. 2010;494:166-177.
27. Yeung EW, Head SI, Allen DG. Gadolinium reduces short-term stretch-induced muscle damage in isolated mdx mouse muscle fibres. J Physiol. 2003;552:449-458.
28. Sequeira VB, Rybchyn MS, Gordon-Thomson C, et al. Opening of chloride channels by 1a, 25-dihydroxyvitamin D3 contributes to photoprotection against UVR-induced thymine dimers in keratin-ocytes. J Invest Dermatol. 2013;133:776-782.
29. Lou YR, Molnár F, Peräkylä M, et al. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol. 2010;118:162-170.
30. Calkhoven CF, Ab G. Multiple steps in the regulation of transcription-factor level and activity. Biochem J. 1996;317(pt 2):329-342.
31. Wang TT, Tavera-Mendoza LE, Laperriere D, et al. Large-scale in silico and microarray-based identification of direct 1, 25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005;19:2685-2695.
32. Li YC, Pirro AE, Demay MB. Analysis of vitamin D-dependent calcium-binding protein messenger ribonucleic acid expression in mice lacking the vitamin D receptor. Endocrinology. 1998;139:847-851.
33. Wang YZ, Christakos S. Retinoic acid regulates the expression of the calcium binding protein, calbindin-D28K. Mol Endocrinol. 1995; 9:1510-1521.
34. Salehi-Tabar R, Nguyen-Yamamoto L, Tavera-Mendoza LE, et al. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proc Natl Acad Sci USA. 2012;109:18827-18832.
35. Rabilloud T. Use of thiourea to increase the solubility of membrane proteins in two-dimensional electrophoresis. Electrophoresis. 1998; 19:758-760.
36. Hizóh I, Sträter J, Schick CS, Kübler W, Haller C. Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity. Nephrol Dial Transplant. 1998;13:911-918.
37. Peach M, Marsh N, Macphee DJ. Protein solubilization: attend to the choice of lysis buffer. Methods Mol Biol. 2012;869:37-47.
38. Anderson PH, Lam NN, Turner AG, et al. The pleiotropic effects of vitamin D in bone. J Steroid Biochem Mol Biol. 2013;136:190-194.
39. Lin R, Nagai Y, Sladek R, et al. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol. 2002;16:1243-1256.
40. Brumbaugh PF, Haussler MR. 1 a, 25-dihydroxycholecalciferol receptors in intestine. I. Association of 1 a, 25-dihydroxycholecalcif-erol with intestinal mucosa chromatin. J Biol Chem. 1974;249: 1251-1257.
41. Neville PF, DeLuca HF. The synthesis of [1, 2-3H]vitamin D3 and the tissue localization of a 0. 25-mu-g (10IU) dose per rat. Biochemistry. 1966;5:2201-2207.
42. Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF. Target cells for 1, 25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science. 1979;206:1188-1190.
43. Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys. 2012;523:123-133.
44. Rodman JS, Baker T. Changes in the kinetics of muscle contraction in vitamin D-depleted rats. Kidney Int. 1978;13:189-193.
45. Curry OB, Basten JF, Francis MJ, Smith R. Calcium uptake by sarcoplasmic reticulum of muscle from vitamin D-deficient rabbits. Nature. 1974;249:83-84.
46. Pleasure D, Wyszynski B, Sumner A, et al. Skeletal muscle calcium metabolism and contractile force in vitamin D-deficient chicks. J Clin Invest. 1979;64:1157-1167.
47. Tague SE, Clarke GL, Winter MK, McCarson KE, Wright DE, Smith PG. Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation. JNeurosci. 2011;31:13728-13738.
48. Sinha A, Hollingsworth KG, Ball S, Cheetham T. Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab. 2013;98:E509-E513.
49. Bouillon R, Verstuyf A. Vitamin D, mitochondria, and muscle. J Clin Endocrinol Metab. 2013;98:961-963.
50. Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A. Swimming behaviour and post-swimming activity in vitamin D receptor knockout mice. Brain Res Bull. 2006;69:74-78.
51. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Impaired motor performance in mice lacking neurosteroid vitamin D receptors. Brain Res Bull. 2004;64:25-29.
52. Bhalla AK, Wojno WC, Goldring MB. Human articular chondrocytes acquire 1, 25-(OH)2 vitamin D-3 receptors in culture. Biochim Biophys Acta. 1987;931:26-32.
53. Gascon-Barré M, Demers C, Mirshahi A, Néron S, Zalzal S, Nanci A. The normal liver harbors the vitamin D nuclear receptor in non-parenchymal and biliary epithelial cells. Hepatology. 2003;37: 1034-1042.
54. Ding N, Yu RT, Subramaniam N, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601-613.
55. Haddad JG, Fraser DR, Lawson DE. Vitamin D plasma binding protein. Turnover and fate in the rabbit. J Clin Invest. 1981;67: 1550-1560.
56. Endo I, Inoue D, Mitsui T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology. 2003;144:5138-5144.
57. Krishnaveni GV, Veena SR, Winder NR, et al. Maternal vitamin D status during pregnancy and body composition and cardiovascular risk markers in Indian children: the Mysore Parthenon Study. Am J Clin Nutr. 2011;93:628-635.
58. Max D, Brandsch C, Schumann S, et al. Maternal vitamin D deficiency causes smaller muscle fibers and altered transcript levels of genes involved in protein degradation, myogenesis, and cytoskeleton organization in the newborn rat. Mol Nutr Food Res. 2014;58:343-352.
59. Clements MR, Fraser DR. Vitamin D supply to the rat fetus and neonate. J Clin Invest. 1988;81:1768-1773.
60. Reschly EJ, Krasowski MD. Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr Drug Metab. 2006;7:349-365.
61. Costa EM, Blau HM, Feldman D. 1, 25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology. 1986;119:2214-2220.
62. Boland R, Norman A, Ritz E, Hasselbach W. Presence of a 1, 25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts. Biochem Biophys Res Commun. 1985;128:305-311.
63. Sandgren ME, Brönnegärd M, DeLuca HF. Tissue distribution of the 1, 25-dihydroxyvitamin D3 receptor in the male rat. Biochem Biophys Res Commun. 1991;181:611-616.
64. Buitrago C, Boland R, de Boland AR. The tyrosine kinase c-Src is required for 1, 25(OH)2-vitaminD3 signalling to the nucleus in muscle cells. Biochim Biophys Acta. 2001;1541:179-187.
65. Buitrago C, Vazquez G, De Boland AR, Boland RL. Activation of Src kinase in skeletal muscle cells by 1, 1, 25-(OH(2))-vitamin D(3) correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction. J Cell Biochem. 2000;79:274-281.
66. Boland R, De Boland AR, Buitrago C, et al. Non-genomic stimulation of tyrosine phosphorylation cascades by 1, 25(OH)(2)D(3) by VDR-dependent and-independent mechanisms in muscle cells. Steroids. 2002;67:477-482.
67. Buitrago C, Boland R. Caveolae and caveolin-1 are implicated in 1a, 25(OH)2-vitamin D3-dependent modulation of Src, cascades and VDR localization in skeletal muscle cells. JSteroid Biochem Mol Biol. 2010;121:169-175.